Vyome Holdings, Inc. (HIND) Stock Price & Analysis
Vyome Holdings, Inc. (HIND) closed at USD 1.91 on Thursday, October 15, 2026, down 0.15% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 1.91; the Oct 15, 2026 session ranged USD 1.83–1.93 on volume of 14,889 shares. Market capitalization is $13.41M, with a 52-week range of USD 1.75–6.56 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HIND.md
Key facts (HIND)
- Analysts: Buy (mean 1.67 on a 1–5 scale) (3 analysts), mean target USD 8.83 (range 3.5–15).
- Total return with dividends: 1Y -62.3% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.
Analysts (HIND)
Consensus Buy (mean 1.67 on a 1–5 scale), 3 analysts; mean target USD 8.83 (low 3.5, high 15).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-03 | Chardan Capital | Initiated | Buy | $3.5 |
Total return (dividends reinvested) (HIND)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -62.3% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -62.4% | -92.6% |
| Volatility (annualized) | 76.1% | 121.1% |
| Max drawdown | -70.0% (Nov 2025→May 2026) | -100.0% (Oct 2021→May 2026) |
Key Statistics (as of October 16, 2026 at 05:49 UTC)
| Price | USD 1.91 |
|---|---|
| Change | ▼ 0.15% (down) |
| Previous Close | USD 1.91 |
| Open | USD 1.9 |
| Day Range | USD 1.83 – 1.93 |
| 52-Week Range | USD 1.75 – 6.56 |
| Volume | 14,889 shares |
| Market Cap | $13.41M |
| Exchange | NCM |
Technical Analysis (HIND)
Nexqual's technical model rates HIND "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:49 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.79 (neutral) |
| vs SMA50 | Below (USD 2.1) |
| MACD | -0.03 (negative) |
Analyst Ratings (HIND)
Wall Street analysts rate HIND "Buy" based on 3 analysts, with a mean price target of USD 8.83 (range USD 3.5–15), per Nexqual as of October 16, 2026 at 05:49 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 8.83 |
| High Target | USD 15 |
| Low Target | USD 3.5 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (HIND)
| Revenue Estimate | $0 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.1 vs est -0.19 ▲ beat |
| 2025-09-30 | USD -3.12 vs est -0.11 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Financials & Fundamentals (HIND)
| Total Revenue | $129,725 |
|---|---|
| Revenue Growth (latest quarter, YoY) | -46.00% |
| Gross Margin | +52.74% |
| Operating Margin | -3200.02% |
| Profit Margin | +0.00% |
| ROE | -999.17% |
| Debt / Equity | 0 |
| Current Ratio | 4.37 |
| Total Cash | $7.89M |
| Total Debt | $17,310 |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Ownership (HIND)
| Insider Ownership | +52.88% |
|---|---|
| Institutional Ownership | +2.18% |
| Shares Outstanding | 7.02M |
| Float | 3.65M |
| Short % of Float | +0.58% |
Source: Nexqual, October 16, 2026 at 05:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 87.97 | ▲ 1.57% |
| BLTE | Belite Bio, Inc | USD 152.62 | ▲ 0.49% |
| IOVA | Iovance Biotherapeutics, Inc. | USD 14.72 | ▲ 1.52% |
| PRAX | Praxis Precision Medicines, Inc | USD 248.24 | ▲ 2.01% |
| IONS | Ionis Pharmaceuticals, Inc. | USD 44.12 | ▲ 4.11% |
| SYRE | Spyre Therapeutics, Inc. | USD 80.1 | ▼ 0.44% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt